Work

Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic

Year: 2022

Type: article

Abstract: This cross-sectional study assesses whether a change occurred in reporting of serious adverse events for patients in oncology clinical trials in the US during the COVID-19 pandemic.

Source: JAMA Oncology

DOI: 10.1001/jamaoncol.2022.4919

Authors: Meera V. Ragavan, Nichole Legaspi, Alyssa LaLanne, Julian C. Hong, Eric J. Small, Hala T. Borno

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: COVID-19 and healthcare impacts

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4307432342

FWCI: 0.732

Cites: 6

Cited by: 7

Related to: 10